Autros Acquisition, Guardian Software May Boost Baxter Public Safety Image
This article was originally published in The Gray Sheet
Executive Summary
Recent patient safety-related measures taken by Baxter International may help improve the firm's public image after a series of recalls and warning letters related to Baxter dialyzers and infusion pumps
You may also be interested in...
Baxter dialyzers
Planned closure of the firm's Ronneby, Sweden and Miami Lakes, Florida plants, which made recently discontinued A-series hemodialyzer components, is announced Nov. 26. The Swedish filter plant and the Florida filter fiber facility employed 158 and 98 people, respectively. A small team will remain at both locations to continue ongoing investigations into more than 50 deaths worldwide that appear linked to a processing fluid residue ("The Gray Sheet" Nov. 12, 2001, p. 16). Baxter has agreed to pay the families of 10 fatalities in Spain $289,000 each under a settlement agreement; the families are asking the Spanish government to drop a planned lawsuit. A Swedish criminal investigation is ongoing...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.